Of courts the two old Supreme’s Sam Alito and his side kick Clarance Thomas did NOT agree….
A Pew Polling of the issue finds 60% of Americans feel abortion, in some form should be available to Americans in most cases…
The justices did not explain their reasoning, but the decision came over the objections of Justices Clarence Thomas and Samuel A. Alito Jr….
…
The court’s action extends a brief pause on the appellate court decision Alito previously put in place. But the Thursday order is not the end of the legal case brought by the state of Louisiana, which centers on whether women in states that ban or restrict abortion can legally access the medication.
Mifepristone is part of a typical two-drug combination for medication abortions, which have become the most common way of ending pregnancies in the United States.
In the years after Roe was overturned, abortion pills have become amajor battleground for legal fights over the procedure.
The Supreme Court’s emergency ruling arose from a lawsuit by Louisiana, which has a near-total ban on abortion, against the Food and Drug Administration. The high court’s ruling remains in effect while that case plays out….
…
Earlier this month, the U.S. Court of Appeals for the 5th Circuit temporarily reinstated the in-person requirement at Louisiana’s request. The following day, two drugmakers appealed that ruling to the Supreme Court.
The greater availability of mifepristone has frustrated antiabortion groups and Republicans, who expected the post-Roe era to bring a drop in abortions. Instead, abortions have increased, largely because drugs such as mifepristone can be prescribed remotely via telehealth providers.
Conservative attorneys and elected officials in states with abortion bans have since looked to curb access to abortion pills and punish the providers who mail them across state lines….
…
After the appeals court issued its ruling May 1, companies that make mifepristone and a generic version asked the Supreme Court to block the ruling. Alito issued a one-week administrative stay on May 4 to give the justices time to consider the appeals by Danco Laboratories, the maker of the drug, and GenBioPro, which manufacturers a generic version.
The legal action has received considerable and immediate attention. More than 20 Democratic-led states and 259 members of Congress who support abortion rights submitted friend-of-the-court briefs backing the drugmakers’ appeals….
…
Five other GOP-led states with abortion bans are making claims similar to Louisiana’s in separate cases aiming to curtail abortion pill access.
In a closely watched Supreme Court case in 2024, the justices ruled that antiabortion doctors did not have legal standing to challenge the FDA’s approval of mifepristone. The decision preserved access to the drug. Three states have since revived that challenge.
Danco spokeswoman Abby Long said in a statement the company was gratified with the Thursday ruling.
“We are pleased that a safe and effective drug Americans depend on will continue to be available while this litigation proceeds,” she said….
Note….
I’m no lawyer but I see this case as ALSO about one state stoppimng naother state from allowing things….
Leave a Reply
You must be logged in to post a comment.